E-cigarettes: Challenges for Clinicians

Jonathan Foulds, PhD. is a Professor of Public Health Sciences and Psychiatry at Penn State University, College of Medicine.He trained as a clinical psychologist at the University of Glasgow, and obtained his PhD at the Institute of Psychiatry, University of London. He has spent most of his career developing and evaluating methods to help smokers beat their addiction to tobacco. He was a founding member and Vice President of the Association for the Treatment of Tobacco Use and Dependence (ATTUD). He has published over 100 scientific papers and book chapters on tobacco and nicotine and has been invited to speak on smoking cessation in over 17 countries. He acts as a consultant to pharmaceutical companies developing smoking cessation products, and has testified to FDA on behalf of the Society for Research on Nicotine and Tobacco on regulation of nicotine replacement therapies. He is Co-director of the NIH-funded Penn State Tobacco Center of Regulatory Science. He continues to treat addicted smokers, teach on smoking cessation and conduct research on tobacco and health at Penn State College of Medicine in Hershey, PA.

Pam Ling is a Professor of Medicine in the Division of General Internal Medicine and Director of the Center for Tobacco Control Research and Education. Her research is on tobacco, media, and social marketing with an emphasis on young people. She focuses on understanding how tobacco marketing encourages youth and young adults to initiate tobacco use, and counter-engineering these strategies to improve tobacco control programs. She conducts research on marketing of smokeless tobacco products and other new and alternative tobacco products, including electronic cigarettes. The goal of this work is to use market research strategies to improve clinical, policy, and public health interventions. She also directs the Postdoctoral Research Fellowship Training Program and sees patients as a primary care provider.

Thomas J. Payne, PhD is a Professor with Tenure in the Department of Otolaryngology and Communicative Sciences at the University of Mississippi Medical Center (UMMC). He received his doctorate in clinical psychology from the State University of New York at Binghamton in 1987. He served as Associate Director of the UMMC / VAMC Psychology Residency Consortium and Director of Behavioral Medicine Consultation at the Jackson VA Medical Center until 2000, when he became a full time UMMC faculty member. He is currently the Director of the ACT Center for Tobacco Treatment, Education and Research . In this capacity, he provides guidance and oversees all clinical activities conducted within the ACT Center Statewide Tobacco Treatment Network. Dr. Payne regularly conducts a variety of tobacco training workshops for healthcare professionals in Mississippi and nationally spanning a variety of topics, including an intensive program for those interested in becoming a Certified Tobacco Treatment Specialist. He has served on Pfizer’s Speaker’s Panel, and was appointed as a Knowledge Opinion Leader. Dr. Payne has been Principal Investigator or Investigator on several NIH, pharmaceutical industry and state ‐ based grants. He currently receives funding from the Mississippi State Department of Health, National Institute for Drug Abuse (NIDA), and the Food and Drug Administration, as an Investigator on a Tobacco Centers of Regulatory Science (TCORS) grant. Dr. Payne is a charter member of the sociocultural research team of the Jackson Heart Study, a large NHLBI ‐ funded longitudinal cohort study of cardiovascular risk and disease in African Americans. His tobacco research interests include the genetics of nicotine dependence, healthcare provider training, predictors of treatment outcome, and pharmacotherapy. He is a member and has served on the boards of national organizations, and is currently President of the Association for the Treatment of Tobacco Use and Dependence. Dr. Payne is a Fellow in the Society of Behavioral Medicine, has provided consultation at the institutional, organizational, and state level. He has authored approximately 100 peer ‐ reviewed publications, and routinely provides scholarly reviews for scientific journals and a funding agencies.